RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether a pill called zanubrutinib could help adults with a specific type of aggressive lymphoma that had returned or stopped responding to prior treatments. The trial focused on people whose cancer had a particular genetic change (CD79B mutation). Participants …
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New combo drugs tested in fight against Tough-to-Treat lymphoma
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of two different drug combinations for people with an aggressive type of lymphoma (DLBCL) that has returned or stopped responding to prior treatment. The trial involved 53 patients who were not eligible for stem c…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC